LIGAND PHARMACEUTICALS INC GLUCN CONT RT
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC GLUCN CONT RT COM, CUSIP 53220K181.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC GLUCN CONT RT COM, CUSIP 53220K181.